EUR 3.55
(-2.74%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -23 Million EUR | 0.72% |
2022 | -23.17 Million EUR | -103.08% |
2021 | -11.41 Million EUR | -30.82% |
2020 | -8.72 Million EUR | -10.54% |
2019 | -7.89 Million EUR | 48.74% |
2018 | -15.39 Million EUR | 9.88% |
2017 | -17.08 Million EUR | -84.56% |
2016 | -9.25 Million EUR | -62.83% |
2015 | -5.68 Million EUR | 0.72% |
2014 | -5.72 Million EUR | -24.76% |
2013 | -4.58 Million EUR | 2.52% |
2012 | -4.7 Million EUR | -13.26% |
2011 | -4.15 Million EUR | -8.66% |
2010 | -3.82 Million EUR | 11.61% |
2009 | -4.32 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -12.71 Million EUR | 0.0% |
2023 Q2 | -11.1 Million EUR | 0.0% |
2023 Q4 | -11.92 Million EUR | 0.0% |
2023 FY | -23 Million EUR | 0.72% |
2022 Q4 | -12.41 Million EUR | 0.0% |
2022 FY | -23.17 Million EUR | -103.08% |
2022 Q2 | -10.89 Million EUR | 0.0% |
2021 Q4 | -7.09 Million EUR | 0.0% |
2021 FY | -11.41 Million EUR | -30.82% |
2021 Q2 | -4.34 Million EUR | 0.0% |
2020 Q2 | -4.44 Million EUR | 0.0% |
2020 Q4 | -4.26 Million EUR | 0.0% |
2020 FY | -8.72 Million EUR | -10.54% |
2019 Q2 | -4.19 Million EUR | 0.0% |
2019 FY | -7.89 Million EUR | 48.74% |
2019 Q4 | -3.74 Million EUR | 0.0% |
2018 Q4 | -6.01 Million EUR | 0.0% |
2018 FY | -15.39 Million EUR | 9.88% |
2018 Q2 | -9.08 Million EUR | 0.0% |
2017 FY | -17.08 Million EUR | -84.56% |
2017 Q4 | -8.38 Million EUR | 0.0% |
2017 Q2 | -8.7 Million EUR | 0.0% |
2016 FY | -9.25 Million EUR | -62.83% |
2016 Q2 | -3.63 Million EUR | 0.0% |
2016 Q4 | -5.62 Million EUR | 0.0% |
2015 Q2 | -2.55 Million EUR | 0.0% |
2015 FY | -5.68 Million EUR | 0.72% |
2015 Q4 | -3.13 Million EUR | 0.0% |
2014 FY | -5.72 Million EUR | -24.76% |
2014 Q4 | -2.32 Million EUR | 0.0% |
2014 Q2 | -2.17 Million EUR | 0.0% |
2013 Q2 | -2.42 Million EUR | 0.0% |
2013 Q4 | -2.16 Million EUR | 0.0% |
2013 FY | -4.58 Million EUR | 2.52% |
2012 Q4 | - EUR | 0.0% |
2012 FY | -4.7 Million EUR | -13.26% |
2012 Q2 | - EUR | 0.0% |
2011 Q4 | - EUR | 0.0% |
2011 FY | -4.15 Million EUR | -8.66% |
2010 FY | -3.82 Million EUR | 11.61% |
2009 FY | -4.32 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Affluent Medical SA | -13.06 Million EUR | -76.075% |
Bluelinea Société Anonyme | -1.61 Million EUR | -1326.584% |
Carmat SA | -52.51 Million EUR | 56.195% |
Diagnostic Medical Systems S.A. | -2.26 Million EUR | -915.717% |
Euromedis Groupe | -5.55 Million EUR | -313.986% |
Eurobio Scientific Société anonyme | 10.14 Million EUR | 326.861% |
Ikonisys S.A. | -2.19 Million EUR | -948.717% |
Implanet S.A. | -6.15 Million EUR | -273.535% |
SpineGuard SA | -3.97 Million EUR | -478.608% |
Theraclion SA | -3.15 Million EUR | -629.423% |
Euroapi S.A. | -234.3 Million EUR | 90.181% |
Guerbet SA | 38.67 Million EUR | 159.492% |
Ion Beam Applications SA | 5.09 Million EUR | 551.807% |
Koninklijke Philips N.V. | -115 Million EUR | 79.995% |
Sequana Medical NV | -29.49 Million EUR | 21.991% |